Product Description: SGD-1910 is a agent-linker conjugate for ADC by using the antitumor antibiotic, pyrrolobenzodiazepine (PBD, a cytotoxic DNA crosslinking), linked via the cleavable linker MC-Val-Ala[1].
Applications: Cancer-programmed cell death
Formula: C60H64N8O12
References: [1]John A Hartley. Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy. Expert Opin Biol Ther. 2020 Jun 16;1-13./[2]Jeffrey SC, et al. A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology. Bioconjug Chem. 2013 Jul 17;24(7):1256-63.
CAS Number: 1342820-51-2
Molecular Weight: 1089.20
Compound Purity: 95.95
Research Area: Cancer
Solubility: DMSO : 50 mg/mL (ultrasonic)
Target: Drug-Linker Conjugates for ADC